Applied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3'25 Financial Results Report in Mid-August

Rhea-AI Summary

Applied DNA Sciences (NASDAQ:APDN), a PCR-based DNA technologies company, announced it will resume its regular quarterly investor call schedule. The company will begin this practice with its fiscal third quarter 2025 financial results release, scheduled for mid-August 2025. As part of this transition, Applied DNA has cancelled its previously planned intra-quarter investor call that was set for June 17, 2025.

News Market Reaction – APDN

+9.52%

+9.52% Session move

In the trading session that priced this news, APDN gained 9.52%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

STONY BROOK, NY / ACCESS Newswire / June 16, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced that it will resume a regular quarterly investor call schedule, beginning with the release of its fiscal third quarter 2025 financial results in mid-August 2025. In alignment with this resumption, the Company has cancelled its previously scheduled intra-quarter investor call for June 17, 2025.

About Applied DNA Sciences

Applied DNA Sciences is a biotechnology company developing technologies to produce and detect deoxyribonucleic acid ("DNA"). Using the polymerase chain reaction ("PCR") to enable both the production and detection of DNA, we operate in two business markets: (i) the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and the development and sale of a proprietary RNA polymerase ("RNAP") for use in the production of mRNA therapeutics; and (ii) the detection of DNA and RNA in molecular diagnostics and genetic testing services.

Visit adnas.com for more information. Follow us on X and LinkedIn.

Applied DNA Sciences Contact:

Investor Relations contact:

Sanjay M. Hurry, 917-733-5573, sanjay.hurry@adnas.com
Web: https://investors.adnas.com/

SOURCE: Applied DNA Sciences

View the original press release on ACCESS Newswire

FAQ

When will Applied DNA (APDN) report its Q3 2025 financial results?

Applied DNA will report its fiscal third quarter 2025 financial results in mid-August 2025.

Why did Applied DNA cancel its June 17, 2025 investor call?

Applied DNA cancelled its June 17 call as part of its transition to resuming regular quarterly investor calls, with the next call scheduled for mid-August 2025.

What is Applied DNA's (APDN) new investor call schedule?

Applied DNA is resuming a regular quarterly investor call schedule, beginning with its fiscal Q3 2025 results in mid-August 2025.

What type of technology does Applied DNA (APDN) specialize in?

Applied DNA Sciences specializes in PCR-based DNA technologies.